As Senior Director, Matthew works closely with other members of the administration, advisors, and outside partners to address Foregen's unique challenges and lead its team of dedicated staff. Previously, he helped to establish Foregen's European financial network, co-authored Foregen's first published paper, and has spoken on behalf of the company to international groups, medical and pharmaceutical conglomerates, and members of the international media.